Full Spectrum Endoscopy Detects Significantly More Polyps
By HospiMedica International staff writers Posted on 31 Mar 2014 |

Image: The EndoCoice Fuse system control panel (Photo courtesy of Endochoice).
A pivotal comparison study shows that full spectrum endoscopy dramatically outperforms standard forward-viewing colonoscopy (SFV).
Researchers at the Rambam Health Care Campus (Haifa, Israel) conducted an international randomized trial in Israel, the Netherlands, and the USA involving 185 participants (18–70 years of age) referred for colorectal cancer screening, polyp surveillance, or diagnostic assessment. The patients underwent same-day, back-to-back tandem colonoscopy; 48% were randomly assigned to receive SFV first, and 52% to receive full-spectrum colonoscopy with the EndoChoice Fuse System colonoscope first. The primary endpoint was adenoma miss rates.
The results showed that by per-lesion analysis, the adenoma miss rate was significantly lower in patients in the full-spectrum endoscopy group (7%) than in those in the SFV procedure group (41%). Full-spectrum endoscopy missed 5 adenomas in 5 patients in whom an adenoma had already been detected with first-pass SFV; none of these missed adenomas that were advanced. SFV, on the other hand, missed 20 adenomas in 15 patients; of those, 3 were advanced adenomas. Five minor adverse events were reported including vomiting, diarrhoea, cystitis, gastroenteritis, and bleeding. The study was published in the March 2014 issue of the Lancet Oncology.
“As the gold standard for colorectal cancer screening, standard forward-viewing colonoscopy still misses a significant percentage of precancerous polyps due to inadequate visualization of the many folds and bends of the colon,” said lead author Ian Gralnek, MD, of the Rambam department of gastroenterology. “These study results confirm that Fuse is an important technological advancement in colorectal cancer screening that significantly improves visualization and has the potential to improve screening outcomes for many patients.”
“The results of this study support our greatest priority as physicians, which is to miss fewer precancerous polyps and improve the quality of our colonoscopies,” added Dr. Gralnek. “It is important for doctors and their patients to know the Fuse endoscopy platform is now available and has the ability to significantly increase adenoma detection rates.”
For the study the researchers used the EndoChoice (Atlanta, GA, USA) Fuse system, which uses three small cameras at the tip of a flexible gastrointestinal endoscope. By using three cameras, the system allows physicians to see nearly twice as much surface area as they can with traditional endoscopes, since the wider angles allow examination of folds that occur naturally in the colon and stomach anatomy, problem areas that can easily go undetected when using traditional one-camera endoscopes.
Related Links:
Rambam Health Care Campus
EndoChoice
Researchers at the Rambam Health Care Campus (Haifa, Israel) conducted an international randomized trial in Israel, the Netherlands, and the USA involving 185 participants (18–70 years of age) referred for colorectal cancer screening, polyp surveillance, or diagnostic assessment. The patients underwent same-day, back-to-back tandem colonoscopy; 48% were randomly assigned to receive SFV first, and 52% to receive full-spectrum colonoscopy with the EndoChoice Fuse System colonoscope first. The primary endpoint was adenoma miss rates.
The results showed that by per-lesion analysis, the adenoma miss rate was significantly lower in patients in the full-spectrum endoscopy group (7%) than in those in the SFV procedure group (41%). Full-spectrum endoscopy missed 5 adenomas in 5 patients in whom an adenoma had already been detected with first-pass SFV; none of these missed adenomas that were advanced. SFV, on the other hand, missed 20 adenomas in 15 patients; of those, 3 were advanced adenomas. Five minor adverse events were reported including vomiting, diarrhoea, cystitis, gastroenteritis, and bleeding. The study was published in the March 2014 issue of the Lancet Oncology.
“As the gold standard for colorectal cancer screening, standard forward-viewing colonoscopy still misses a significant percentage of precancerous polyps due to inadequate visualization of the many folds and bends of the colon,” said lead author Ian Gralnek, MD, of the Rambam department of gastroenterology. “These study results confirm that Fuse is an important technological advancement in colorectal cancer screening that significantly improves visualization and has the potential to improve screening outcomes for many patients.”
“The results of this study support our greatest priority as physicians, which is to miss fewer precancerous polyps and improve the quality of our colonoscopies,” added Dr. Gralnek. “It is important for doctors and their patients to know the Fuse endoscopy platform is now available and has the ability to significantly increase adenoma detection rates.”
For the study the researchers used the EndoChoice (Atlanta, GA, USA) Fuse system, which uses three small cameras at the tip of a flexible gastrointestinal endoscope. By using three cameras, the system allows physicians to see nearly twice as much surface area as they can with traditional endoscopes, since the wider angles allow examination of folds that occur naturally in the colon and stomach anatomy, problem areas that can easily go undetected when using traditional one-camera endoscopes.
Related Links:
Rambam Health Care Campus
EndoChoice
Latest Surgical Techniques News
- Easy-To-Apply Gel Could Prevent Formation of Post-Surgical Abdominal Adhesions
- Groundbreaking Leadless Pacemaker to Prevent Invasive Surgeries for Children
- Spectroscopy Technique Improves Surgery for Pediatric Epilepsy Patients
- Bioengineered Arteries Show Promise for Cardiovascular Surgery
- Online Tool Guides Surgical Decisions for Gallbladder Cancer
- Innovative Technology Enables Rapid Life-Saving Surgical Leak Detection
- First-Of-Its-Kind Bioresorbable Implant to Help Children with Rare Respiratory Disease
- Screw-Shaped Magnetic Microrobots to Transform Treatment for Patients with Inoperable Blood Clots
- "Ultra-Rapid" Testing in the OR Could Enable Accurate Removal of Brain Tumors
- Automated Endoscopic Device Obtains Improved Biopsy Results in Single Pass
- World's First Machine Learning Model Combats Wrong-Site Surgery
- Novel Method Combining Heart Biopsy and Device Implantation Reduces Complications Risk
- New Surface Coating Could Prevent Blood Clotting in Medical Devices and Implants
- Dumbbell-Shaped Thrombectomy Device Offers Novel Approach to Cerebral Venous Sinus Thrombosis Treatment
- Novel Catheter Mimics Snake Teeth to Grab Blood Clots
- New Laparoscopic Imaging Technique Accurately Maps Biological Tissue for Minimally Invasive Surgery
Channels
Artificial Intelligence
view channel
Innovative Risk Score Predicts Heart Attack or Stroke in Kidney Transplant Candidates
Heart researchers have utilized an innovative risk assessment score to accurately predict whether patients being evaluated for kidney transplants are at risk for future major cardiac events, such as a... Read more
AI Algorithm Detects Early-Stage Metabolic-Associated Steatotic Liver Disease Using EHRs
Liver disease, which is treatable when detected early, often goes unnoticed until it reaches advanced stages. Metabolic-associated steatotic liver disease (MASLD), the most prevalent form of liver disease,... Read moreCritical Care
view channel
Novel Coating Significantly Extends Longevity of Implantable Biosensors
Wearable and implantable biosensors capable of accurately detecting biological molecules in a non-invasive or minimally invasive way offer enormous potential for monitoring patients’ health and their responses... Read more
Nanogel-Based Drug Delivery Technology to Improve UTI Treatment
Urinary tract infections (UTIs) are not only widespread and costly but also highly debilitating, significantly impacting the quality of life for those affected. The antibiotics commonly used to treat UTIs... Read more
New IV Pole Improves Safety and Ease of Administering IV Medications at Hospital Bedside
Preventable medication errors affect around 500,000 hospitalized patients in the U.S. every year. A significant portion of these errors occur with intravenous (IV) smart pumps, which require a precise... Read morePatient Care
view channel
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more
Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more
Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
A groundbreaking innovation enables hospitals to significantly improve instrument processing time and throughput in operating rooms (ORs) and sterile processing departments. Turbett Surgical, Inc.... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read morePoint of Care
view channel
Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour
Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Smartphone-Enabled, Paper-Based Quantitative Diagnostic Platform Transforms POC Testing
Point-of-care diagnostics are crucial for public health, offering rapid, on-site testing that enables prompt diagnosis and treatment. This is especially valuable in remote or underserved regions where... Read moreBusiness
view channel
Becton Dickinson to Spin Out Biosciences and Diagnostic Solutions Business
Becton, Dickinson and Company (BD, Franklin Lakes, NJ, USA), has announced that its board of directors has unanimously authorized BD management to pursue a plan to separate BD's Biosciences and Diagnostic... Read more